Amgen director gets 665-share stock award

Jacks Tyler reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Jacks Tyler reported acquisition or exercise transactions in this Form 4 filing.

Amgen Inc. director Tyler Jacks reported a compensation-related equity grant rather than an open-market trade. He received 665 shares of common stock via immediately vesting Restricted Stock Units under Amgen’s 2009 Director Incentive Program. After this award, he directly holds 18,284 common shares, including 2,975 dividend equivalents tied to unvested RSUs that will be paid in stock as they vest.

Insider Trade Summary

Grant/Award: 665 shares

Grant/Award 1 txn

Insider Jacks Tyler

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	665	$0.00	$0.00

Holdings After Transaction: Common Stock — 18,284 shares (Direct)

Footnotes (2)

1. F1. The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and vested immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case payment will occur according to the elected deferral schedule.
2. F2. These shares include 2,975 DEs granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.

Key Figures

RSU grant: 665 shares Post-transaction holdings: 18,284 shares Dividend equivalents: 2,975 DEs +1 more

4 metrics

RSU grant 665 shares Common stock received via immediately vesting RSUs on May 19, 2026

Post-transaction holdings 18,284 shares Total Amgen common stock directly held after the grant

Dividend equivalents 2,975 DEs DEs credited to unvested RSUs, payable in common stock

Grant price $0.00 per share Indicates a compensation award, not a market purchase

Key Terms

Restricted Stock Units (RSUs), Amgen Inc. 2009 Director Incentive Program, Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan, dividend equivalents (DEs), +1 more

5 terms

Restricted Stock Units (RSUs) financial

"The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program..."

Restricted stock units (RSUs) are a type of company promise to give employees shares of stock in the future, usually after certain conditions like working for a set time. They are like a gift promised today that you receive later, which can become valuable if the company's stock price goes up. RSUs matter because they are a way companies reward employees and can be a significant part of compensation.

Amgen Inc. 2009 Director Incentive Program financial

"RSUs were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended..."

Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan financial

"granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan..."

dividend equivalents (DEs) financial

"These shares include 2,975 DEs granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan..."

dividend reinvestment plan financial

"2,975 DEs granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan."

A dividend reinvestment plan lets shareholders automatically use cash dividends to buy more shares of the same company instead of receiving the money. It matters to investors because it turns regular payouts into a steady way to grow ownership and take advantage of compound returns—like having your savings automatically buy additional slices of a pie over time—while often reducing transaction costs and smoothing purchase timing.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Amgen (AMGN) director Tyler Jacks report in this Form 4?

Tyler Jacks reported receiving 665 shares of Amgen common stock through an immediately vesting Restricted Stock Unit grant. This is a compensation-related award, not an open-market stock purchase or sale, and reflects standard director equity compensation under Amgen’s incentive programs.

How many Amgen (AMGN) shares does Tyler Jacks hold after this transaction?

After the grant, Tyler Jacks directly holds 18,284 shares of Amgen common stock. This total includes shares from the new award and 2,975 dividend equivalents linked to unvested RSUs that will convert into shares as those RSUs vest over time.

Was Tyler Jacks’ Amgen (AMGN) Form 4 transaction a stock purchase or sale?

The filing shows a grant of 665 shares at a price of $0.00 per share, coded as an award acquisition. This indicates a compensation-related grant of Restricted Stock Units, not an open-market purchase or sale initiated by the director on a stock exchange.

What are the key terms of Tyler Jacks’ Amgen (AMGN) RSU grant?

The Restricted Stock Units were granted under Amgen’s 2009 Director Incentive Program and vested immediately. Each vested RSU is paid in one share of Amgen common stock, and directors may defer payment so shares are delivered later according to an elected deferral schedule.

What do the 2,975 DEs reported in the Amgen (AMGN) Form 4 represent?

The 2,975 DEs are dividend equivalents credited on unvested RSUs under Amgen’s equity incentive plan. They are paid out in Amgen common shares on a one-to-one basis when the associated RSUs vest, plus a cash payment for any remaining fractional share amount.

Does this Amgen (AMGN) Form 4 indicate any remaining derivative positions for Tyler Jacks?

The derivative section of the filing is empty, indicating no derivative securities such as stock options or similar instruments are reported as remaining positions in this Form 4. The disclosure focuses on common stock held directly and equity granted through RSUs and dividend equivalents.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/21/2026 - 07:04 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Jacks Tyler

(Last) (First) (Middle)

ONE AMGEN CENTER DRIVE

(Street)

THOUSAND OAKS CALIFORNIA 91320-1799

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
AMGEN INC [ AMGN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/19/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/19/2026		A		665	A	$0	18,284(1)(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and vested immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case payment will occur according to the elected deferral schedule.

2. These shares include 2,975 DEs granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.

	/s/ Tyler Jacks	05/21/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)